These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10946527)

  • 1. Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia.
    Saunders E; Ferdinand K; Yellen LG; Tonkon MJ; Krug-Gourley S; Poland M
    J Natl Med Assoc; 2000 Jul; 92(7):319-26. PubMed ID: 10946527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
    Dujovne CA; Knopp R; Kwiterovich P; Hunninghake D; McBride TA; Poland M
    Mayo Clin Proc; 2000 Nov; 75(11):1124-32. PubMed ID: 11075741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
    Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
    Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
    Yu WC; Chen CH; Tsao HM; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
    Isaacsohn J; Insull W; Stein E; Kwiterovich P; Patrick MA; Brazg R; Dujovne CA; Shan M; Shugrue-Crowley E; Ripa S; Tota R;
    Clin Cardiol; 2001 Sep; 24(9 Suppl):IV1-9. PubMed ID: 11594407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
    Hunninghake DB
    Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E;
    Am Heart J; 2002 Dec; 144(6):1036-43. PubMed ID: 12486428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
    Hunninghake D; Insull W; Knopp R; Davidson M; Lohrbauer L; Jones P; Kafonek S
    Am J Cardiol; 2001 Sep; 88(6):635-9. PubMed ID: 11564386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia].
    Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
    Rev Med Interne; 1999 Aug; 20 Suppl 3():393s-398s. PubMed ID: 10480191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.
    Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Ogawa N; Goto Y
    Atherosclerosis; 2002 Jun; 162(2):373-9. PubMed ID: 11996957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: a one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness.
    McPherson R; Hanna K; Agro A; Braeken A;
    Clin Ther; 2001 Sep; 23(9):1492-507. PubMed ID: 11589262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia.
    Simons LA
    Am J Cardiol; 2002 Oct; 90(7):737-40. PubMed ID: 12356387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.
    Stein E; Isaacsohn J; Stoltz R; Mazzu A; Liu MC; Lane C; Heller AH
    Am J Cardiol; 1999 May; 83(10):1433-6. PubMed ID: 10335757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
    Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
    Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemia. International Cerivastatin Study Group.
    Betteridge DJ
    Int J Clin Pract; 1999 Jun; 53(4):243-50. PubMed ID: 10563066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
    Plosker GL; Dunn CI; Figgitt DP
    Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety.
    Stein E
    Am J Cardiol; 1998 Aug; 82(4B):40J-46J. PubMed ID: 9737645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.